Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LEAP-THERAPEUTICS-INC-33375941/news/Leap-Therapeutics-to-Present-New-Data-from-Part-A-of-the-DeFianCe-Study-of-DKN-01-Plus-Bevacizumab-a-45549403/?utm_source=whatsapp&utm_medium=social&utm_campaign=share